ABOS - Acumen Pharmaceuticals PEG multiplikatori
Acumen Pharmaceuticals (ABOS) ilmiy hamjamiyat tomonidan miya degeneratsiyasiga qarshi kurashda yetakchi sifatida tan olingan. P/E koeffitsiyenti asoslantirish ko'rsatkichi aktivning bozor qiymatini vizuallashtiradi, bunda 0.00 metriki ushbu darajani belgilaydi. Kompaniyaga tegishli asos Alzheimer tadqiqot markazlari bilan hamkorlikka va hozirda II bosqich sinovlari natijalari kutilayotgan maqsadli ingibitorlarning inqilobiy ishlanmalariga qurilgan.
Acumen Pharmaceuticals (ABOS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi statistikasi:
- balans bo'yicha xususiy kapital ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Acumen Pharmaceuticals|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati acumenpharm.com|ABOS - Kompaniya qarzlari|Qarzlarning balans kapitallashuviga nisbati Acumen Pharma|ABOS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli kredit va qarzlari Acumen Pharmaceuticals|Tezkor likvidlik koeffitsiyenti acumenpharm.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ABOS - Kompaniyaning sof foydasi|Kutilayotgan sof daromad Acumen Pharmaceuticals|ABOS - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Acumen Pharmaceuticals, Inc|ABOS - PEG multiplikatori|EV/EBITDA multiplikatori Acumen Pharma|ABOS - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Acumen Pharmaceuticals|ABOS - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi acumenpharm.com|ABOS - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Acumen Pharmaceuticals
Kompaniyaning fundamental tahlili:Acumen Pharmaceuticals Inc. - ABOS
Daniel O'Connell'ning barqaror rahbarligi Acumen Pharmaceuticals (ABOS) kompaniyasida Altsgeymer kasalligi terapiyasi ishlab chiqilayotgan davrda xarajatlarning qat'iy nazoratini ta'minlaydi. Joriy PEG koeffitsiyentini tahlil qilish orqali investor aksiyalarning daromadlar o'sishiga nisbatan tejamkorligini baholaydi. Ushbu metrika baholashdagi nomutanosibliklarni aniqlash uchun bozor koeffitsiyentini biznes kengayish sur'atlari bilan solishtiradi. Birga solishtirganda pastroq qiymatlar aktivning qadrini past baholaganini anglatadi, bu esa klinik sinovlar bosqichidagi Acumen Pharmaceuticals (ABOS) kompaniyasining investitsiya jozibadorligini tasdiqlaydi.
Raqobatdosh kompaniyalar
Narx-foyda va o‘sish multiplikatori Biogen Inc BIIB|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Regencell Corp RGC|AXSM - Narxning foydaga va o‘sish sur’atiga nisbati|acadia-pharm.com (ACAD) - Narx-foyda va o‘sish multiplikatori|XENE: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Viking Therapeutics Inc (VKTX)|Narxning foydaga va o‘sish sur’atiga nisbati Supernus Pharma|O‘sishni hisobga olgan narx-foyda koeffitsiyenti CPRX (Catalyst Corp)|Narx-foyda va o‘sish multiplikatori DNLI (Denali Therapeutics)|HRMY (harmonybiosciences.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Biohaven BHVN|AMLX (Amylyx Pharmaceuticals Inc) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Trevi Pharma - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti PRAX (Praxis Corp)|AVXL: PEG multiplikatori|ceribell.com (CBLL) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Prothena Corporation plc|ALEC: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Annexon Inc. (ANNX)|Narx-foyda va o‘sish multiplikatori omeros.com OMER|PEG multiplikatori NGNE (Neurogene Inc.)|PEG multiplikatori acimmune.com ACIU|Voyager Therapeutics, Inc. - PEG multiplikatori|Neumora (NMRA) - Narx-foyda va o‘sish multiplikatori|SCLX: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tevogen Bio Inc. (TVGN)|Narx-foyda va o‘sish multiplikatori ACOG|PEG multiplikatori cogrx.com|Narx-foyda va o‘sish multiplikatori IKT (Inhibikase Therapeutics, Inc.)|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati SAVA|PEG multiplikatori ASRT (Assertio)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Coya Therapeutics Inc (COYA)|VistaGen Therapeutics Inc - PEG multiplikatori|Ovid Therapeutics Inc. (OVID) - Narx-foyda va o‘sish multiplikatori|CRVO: PEG multiplikatori|Alterity Therapeutics Limited (ATHE) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Clene Inc|Narxning foydaga va o‘sish sur’atiga nisbati PEPG|Narxning foydaga va o‘sish sur’atiga nisbati Jupiter Neurosciences Inc (JUNS)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati relmada.com|PEG multiplikatori ANVS (Annovis Bio)|PEG multiplikatori Grace Therapeutics Inc GRCE|Firefly Neuroscience Inc - PEG multiplikatori|KLTO: Narxning foydaga va o‘sish sur’atiga nisbati|neurosense-tx.com (NRSN) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda revivapharma.com (RVPH)|Narxning foydaga va o‘sish sur’atiga nisbati MetaVia Inc.|NeurAxis Inc. (NRXS) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|passagebio.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori NEUP (Neuphoria Therapeutics)|minervaneurosciences.com (NERV) - O‘sish sur’atiga tuzatilgan narx-foyda|ATHA: Narx-foyda va o‘sish multiplikatori|ADXN - PEG multiplikatori|alzamend.com (ALZN) - Narxning foydaga va o‘sish sur’atiga nisbati|Cyclerion Therapeutics, Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Protagenic Therapeutics Inc.|O‘sish sur’atiga tuzatilgan narx-foyda Pasithea KTTA|PEG multiplikatori CRGT|PEG multiplikatori Avenue Therapeutics Inc. (ATXI)|PEG multiplikatori BCLI (Brainstorm Cell Therapeutics, Inc.)|CARA - Narx-foyda va o‘sish multiplikatori|CHRO: Narx-foyda va o‘sish multiplikatori|ELYM - PEG multiplikatori|intracellulartherapies.com (ITCI) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Longboard Pharmaceuticals Inc|MRNS (Marinus) - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda NKGen Biotech Corp NKGN|Narxning foydaga va o‘sish sur’atiga nisbati NeuroBo Pharmaceuticals (NRBO)|sagerx.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|Synaptogenix - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti TRVN|VIGL - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati WENA|CERE: PEG multiplikatori
